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INTRODUCTION
Randomized trials have demonstrated that endoscopic screening reduces incidence and mortality from colorectal cancer (1) (2) (3) (4) . Colonoscopy is the primary form of endoscopic screening; over 14 million colonoscopies are performed annually in the United States ( 5 ) . Identifying and removing both adenomatous and serrated polyps during colonoscopy is important, as each are precursors of colorectal cancer (6) (7) (8) (9) (10) . Physicians vary in how oft en they detect pre-cancerous lesions ( 6, (11) (12) (13) (14) and a lower physician adenoma detection rate (ADR) is associated with a higher subsequent rate of interval colorectal cancer ( 10, 11, 15 ) . Given this variation, specialty societies and experts have called for physicians to regularly monitor their performance on ADR ( 16, 17 ) and, increasingly, experts have called for monitoring serrated polyp detection rate (SPDR) as well ( 18, 19 ) .
Th e classifi cation of polyps as adenomatous or serrated is done by a pathologist; thus, an endoscopist's performance on ADR and SPDR is dependent on accurate and consistent pathologist classifi cation. Previous studies have raised concern about variation in polyp classifi cation across pathologists ( 10, 12, 13, 20 , Robert E. Schoen , MD, MPH 5 and Ateev Mehrotra , MD, MPH 1 , 7 OBJECTIVES:
Endoscopist quality measures such as adenoma detection rate (ADR) and serrated polyp detection rates (SPDRs) depend on pathologist classifi cation of histology. Although variation in pathologic interpretation is recognized, we add to the literature by quantifying the impact of pathologic variability on endoscopist performance.
METHODS:
We used natural language processing to abstract relevant data from colonoscopy and related pathology reports performed over 2 years at four clinical sites. We quantifi ed each pathologist's likelihood of classifying polyp specimens as adenomas or serrated polyps. We estimated the impact on endoscopists' ADR and SPDR of sending their specimens to pathologists with higher or lower classifi cation rates.
RESULTS:
We observed 85,526 colonoscopies performed by 119 endoscopists; 50,453 had a polyp specimen, which were analyzed by 48 pathologists. There was greater variation across pathologists in classifi cation of serrated polyps than in classifi cation of adenomas. We estimate the endoscopist's average SPDR would be 0.5% if all their specimens were analyzed by the pathologist in our sample with the lowest classifi cation rate and 12.0% if all their specimens were analyzed by the pathologist with the highest classifi cation rate. In contrast, the endoscopist's average ADR would be 28.5% and 42.4% if their specimens were analyzed by the pathologist with lowest and highest classifi cation rate, respectively.
one study showed the same 20 images of adenomatous and serrated polyps to 168 pathologists, and found substantial variability in classifi cation ( 21 ) . Disagreement across pathologists may be particularly evident in classifi cation of serrated polyps ( 13, 14 ) . One study compared classifi cation of serrated polyps across 20 pathologists and found that inter-pathologist reliability in how polyps were classifi ed was low ( 20 ) . A number of studies have reported a substantial proportion of polyps previously read as hyperplastic were reclassifi ed as sessile serrated adenomas/polyps upon secondary review (22) (23) (24) . Athough these studies highlight variation across pathologists primarily in test specimens, there has been limited prior research on variation among pathologists in real world practice and the impact of this variation on endoscopist quality performance. We used a large multi-site sample of colonoscopy and associated pathology reports to examine the variation in pathologist classification of conventional adenomas and serrated polyps, controlling for the endoscopist who performed the colonoscopy. We use these fi ndings to illustrate how an endoscopist's ADR and SPDR could be aff ected by variation in pathologic classifi cation of polyps.
METHODS

Sample of colonoscopies
Our data set included colonoscopies between 1 October 2013 and 30 September 2015 at four clinical sites across the United States. Th e clinical sites were selected to vary in geographic location and structure of fi nancial incentives related to colonoscopy performance. UPMC is a large mixed academic/non-academic health system based in Western Pennsylvania; the University of North Carolina is an academic center; Central Illinois Endoscopy is a private colonoscopy center in Peoria, Illinois; Kaiser Permanente Washington (formerly Group Health Cooperative) is a staffmodel health maintenance organization in Washington State.
We excluded inpatient colonoscopies, those done on patients under age 40 years, and patients with infl ammatory bowel disease, as these cases likely do not represent screening for colorectal cancer. We chose 40 years as the cutoff instead of 50 years to ensure we captured colonoscopies that were performed for colorectal cancer screening among those with a family history. To ensure suffi cient sample size for our analyses, we excluded colonoscopies performed by low-volume endoscopists (<100 colonoscopies with a polyp removed over 2 years, n =3,068 excluded) or where the pathology specimen was assessed by a low-volume pathologist (<200 colonoscopies with a polyp removed and an associated pathology report over 2 years, n =509 excluded). We conducted sensitivity analyses using two alternative volume cutoff s, to ensure that our results were robust to the chosen volume threshold ( Supplementary Information 1 ).
Aft er these exclusion criteria, our sample included colonoscopy and pathology reports from 91 endoscopists and 32 pathologists from UPMC, 33 endoscopists and 5 pathologists from University of North Carolina, 11 endoscopists and 3 pathologists from Central Illinois Endoscopy, and 17 endoscopists and 8 pathologists from Kaiser Permanente Washington.
Analysis of colonoscopy and pathology reports
We used a natural language processing (NLP) computer program to collect the relevant data from the colonoscopy and associated pathology reports. NLP is a method in which a computer program "reads" free text, automating the manual abstracting otherwise required to extract needed data from colonoscopy and pathology reports. NLP abstraction has been used in a number of studies to assess colonoscopy quality (25) (26) (27) . Details about the NLP program used in the present study and its performance compared with human abstractors have been previously published ( 25, 28, 29 ) . Th e NLP program was highly accurate in adenoma or serrated polyp identifi cation (accuracy>95% for both outcomes) ( 29 ) .
For each colonoscopy report, the NLP program identifi ed the endoscopist and whether a polyp was removed. It also classifi ed up to three indications for the colonoscopy. If a procedure had more than one indication, it was classifi ed based on the following hierarchy: infl ammatory bowel disease, screening without a family history of colorectal cancer, surveillance, screening with a family history of colorectal cancer, and diagnostic. We structured the hierarchy, because, in our review of many colonoscopy reports, oft en incidental indications such as abdominal pain or diarrhea were added to colonoscopies that were primarily for screening purposes. Using this hierarchy, if the indications for a colonoscopy were screening and abdominal pain, it was classifi ed as a screening colonoscopy. We then used patient and date identifi ers to link each colonoscopy report to its corresponding pathology report. In the cases where there were multiple pathology reports corresponding to a single colonoscopy, we retained the pathology report with the latest date, as that was most likely to refl ect the full results of the pathologic analysis.
For each associated pathology report, the NLP program identifi ed which pathologist analyzed the specimens. For each specimen, the NLP program abstracted the location, whether there was an adenoma, and whether there was a polyp that was read as "serrated. " Although we recognize that hyperplastic polyps are also in the family of serrated polyps according to World Health Organization defi nitions ( 30 ), our NLP program did not include hyperplastic polyps in the defi nition of serrated polyps. Current guidelines ( 31 ) are ambiguous on what endoscopists should do with proximal hyperplastic polyps, but do advocate for early follow-up aft er sessile serrated adenomas/polyps. Th erefore, the distinction between hyperplastic polyps and sessile serrated adenomas/polyps is of critical clinical importance ( 31 ) . For the purposes of this analysis, we also did not distinguish between sessile serrated adenomas/ polyps and traditional serrated adenomas because prior literature indicates that the majority of polyps read as serrated are sessile serrated adenomas/polyps. In addition, the terminology used in pathology reports across the sites to describe serrated polyps was inconsistent (see Supplementary Information 2 ); thus, it would not have allowed for more specifi c categorization of types of serrated adenomas.
We categorized location of the polyp into three segments: proximal colon (proximal to the splenic fl exure, >50 cm from anal verge); distal colon (end of the sigmoid colon to the splenic COLON/SMALL BOWEL Variation in Pathologist Polyp Classification fl exure, 35-50 cm from anal verge); and rectosigmoid (sigmoid colon and rectum, ≤35 cm from anal verge). If an adenoma was identifi ed in both a proximal and distal polyps from a given colonoscopy then it was included in both proximal and distal ADR. We chose to distinguish between polyps in the rectosigmoid colon vs. more proximal left colon (descending colon and splenic fl exure) given that small rectosigmoid serrated polyps are considered to be lower risk ( 32, 33 ) . Furthermore, because hyperplastic polyps are far more prevalent than sessile serrated adenomas/polyps in the rectosigmoid colon ( 34 ), we wanted to examine whether pathologists diff ered with respect to identifying serrated polyps in this location. As a sensitivity analysis, we considered an alternative location classifi cation in which we separately classifi ed serrated polyps found in the rectum. In this alternative, we divided the colon into three segments: proximal colon (proximal to the splenic fl exure, >50 cm from anal verge); distal colon (end of the rectum to the splenic fl exure, including the sigmoid colon, 15-50 cm from anal verge); and rectum (rectum only, ≤15 cm from anal verge).
Our unit of analysis was the colonoscopy (rather than specimen bottle) given this is the unit of analysis for endoscopist quality measurement. For simplicity we use the phrasing "number of reports analyzed" to describe the number of colonoscopy exams for which the pathologist analyzed the removed polyps, recognizing that this is a bit of a misnomer as the pathologist does not analyze the report, but rather individual pathologic specimens. All pathology reports in the sample were associated with colonoscopies in which at least one polyp was removed. In the cases where a patient received multiple colonoscopies, all such colonoscopies would be included in the sample.
Measures of pathologist classifi cation
For each pathologist, we calculated an "observed classifi cation rate" for adenomas and serrated polyps. Using adenomas as an example, the observed classifi cation rate was calculated as the number of pathology reports in which the pathologist classifi ed a polyp as an adenoma divided by the total number of pathology reports with a polyp the pathologist analyzed. For example, if a pathologist analyzed 1,000 pathology reports and classifi ed 500 specimens as adenomas, their observed classifi cation rate would be 50%.
In assessing variation across pathologists we also account for variation across endoscopists in identifying pathologic polyps. Some endoscopists are more likely to remove polyps that are adenomas or serrated polyps than others and this variation might impact the pathologists' classifi cation rate. For example, at the extreme, one endoscopist might remove many "polyps" that are normal tissue. A pathologist classifying those polyps would have a lower adenoma classifi cation rate than a pathologist classifying polyps for an endoscopist who is more consistent in only removing pre-cancerous polyps.
We controlled for endoscopist variation in polyp removal in our calculation of each pathologist's "expected classifi cation rate. " Th is methodology builds upon methodology used to evaluate hospital and surgeon mortality and hospital readmissions (35) (36) (37) (38) . Using adenomas as an example, a pathologist's expected classifi cation rate is the proportion of pathology reports analyzed in which we would expect there to be an adenoma, given the endoscopist who performed the colonoscopy. To calculate the expected classifi cation rate, we fi t a logistic regression model where the unit of analysis was each colonoscopy with a polyp removed; the outcome was a binary indicator for whether an adenoma was detected. Th e only predictor variables were endoscopist fi xed eff ects (i.e., a binary yes/ no variable for each of the 119 endoscopists) in our sample. Th e coeffi cients on each of these endoscopist fi xed eff ects are an estimate of the underlying fraction of all polyps sent to any pathologist that are judged to be an adenoma.
We then use these endoscopist fi xed eff ects to calculate a pathologist's expected classifi cation rate. Th e expected classifi cation rate then represents, on average, the proportion of the pathology reports analyzed by the pathologist in which we would expect there to be an adenoma, given the endoscopists performing the colonoscopies. In Supplementary Information 3 we demonstrate how much of the variation across pathologists is accounted for by this adjustment and provide some concrete examples of the expected and observed adenoma classifi cation rates for pathologists. We repeated this procedure for serrated polyps as well as distal, proximal, and rectosigmoid serrated polyps.
To compare classifi cation of polyps across pathologists, we calculated standardized risk ratios-the ratio of the pathologist's observed to expected classifi cation rate for each outcome ( 39 ) . For example, if a pathologist's standardized adenoma classifi cation ratio is greater than one, she was more likely to classify a polyp as an adenoma than our data would predict based only on the endoscopists for whom she analyzed pathology reports.
We chose not to adjust for patient characteristics and colonoscopy indication, because although patient characteristics clearly impact the likelihood of identifying an adenoma during the colonoscopy, it is less clear that they impact whether a polyp is classifi ed as an adenoma by a pathologist. We conducted a sensitivity analysis to assess whether adjusting for patient and colonoscopy factors would aff ect our measurement of pathologist classifi cation rate. Th is analysis included patient age, gender, and colonoscopy indication in generating the "expected classifi cation rate" ( Supplementary Information 4 ) and found these patient characteristics had little impact on overall variation in pathologist classifi cation of these outcomes.
Physician characteristics
To characterize the age and years of practice of the pathologists and endoscopists, we linked our dataset with data from Doximity. Doximity integrates information on physicians from the National Plan and Provider Enumeration System, National Provider Identifi er Registry, and reports from self-registered members, and collaborating hospitals and medical schools. Th is database has been used for other studies of the physician workforce (35) (36) (37) . Years of practice was measured between 2014 and the year of residency completion. We stratifi ed pathologists into three tertiles of years of practice (<8 years, 8-17 years, and 18-46 years). In consultation with physicians at each of the clinical sites, we identifi ed whether each pathologist was specialized in gastroenterology. Pathologists were considered "Gastroenterology (GI) pathologists" if they had either undergone formal subspecialty training in gastrointestinal pathology or if their work consisted mostly or entirely of analysis of gastrointestinal specimens.
Variation analyses
We described the variation across pathologists' standardized classifi cation ratios using the coeffi cient of variation (COV), a measurement of variation calculated as the ratio of a variable's standard deviation to its mean. Higher values of COV indicate greater variability or dispersion of data.
To put our fi ndings in clinical context, we analyzed how an endoscopist's SPDR and ADR would be diff erent if all the polyps they removed were analyzed by the pathologist with the highest, lowest, and 25th percentile or 75th percentile standardized serrated polyp classifi cation and adenoma classifi cation, respectively (see Supplementary Information 5 for details).
RESULTS
Th ere were 85,526 colonoscopies performed by 119 endoscopists in our sample, 50,453 of which had a polyp removed and an associated pathology report ( Table 1 ) . Th e colonoscopies were primarily conducted for screening (47%) or surveillance (32%). Th e patients were roughly equally divided by sex and 71% were between the ages of 50 and 69 years. An adenoma was detected in 35% of the colonoscopies and a serrated polyp was detected in 7%.
Th ere were 48 pathologists who analyzed the 50,453 pathology reports over the 2-year period ( Table 2 ). Over half (63%) of the pathologists were male. Th e median number of colonoscopy pathology reports analyzed by each pathologist in the 2-year period was 997. Th e median number of years in practice for pathologists in the sample was 9. On average, the pathologists analyzed polyps removed by 17 diff erent endoscopists (range 2-36) and endoscopists had their specimens analyzed by an average of 7 pathologists (range 2-18). Most pathologists were not specialized in gastrointestinal pathology (69%). Our sample has a similar gender balance to the national population of pathologists but has a smaller proportion of pathologists with 18 or more years of practice ( Supplementary Information 6 ) .
Th e 119 endoscopists in our sample were also mostly male (79%) and the median number of colonoscopies performed over the 2-year period was 644 ( Table 3 ) . Th e average ADR across the endoscopists was 36% and the average SPDR was 7%.
Variation in pathologists' classifi cation of polyps as adenomas or serrated polyps
We characterized variation across pathologists in their classification through the use of standardized classifi cation ratios (see Supplementary Information 7 for examples of calculations). Th ere was more variation in pathologists' standardized serrated polyp classifi cation ratio (interquartile range (IQR) 0.81-1.12, COV 32.0) than standardized adenoma classifi cation ratio (IQR 0.98-1.02, COV 3.7) ( Figure 1 ). By location in the colon, there was less variation in pathologists' standardized classifi cation ratio for proximal serrated polyps (IQR 0.71-1.07, COV 30.9) compared with distal serrated polyps (IQR 0.40-1.14, COV 66.9) or rectosigmoid serrated polyps (IQR 0.34-1.46, COV 83.8) ( Figure  2 ). Th is diff erential variation in serrated polyp classifi cation by colonic location was consistent in a sensitivity analysis with alternative cutoff s for the colonic segments ( Supplementary Information 8 ).
Impact of variation in pathologist classifi cation rates on endoscopist quality metrics
In our sample, the average SPDR across the 119 endoscopists was 7%. We modeled the SPDR for all 119 endoscopists if all polyp specimens were analyzed by the pathologist with the lowest and highest classifi cation rate, as well as the pathologist at the 25th and 75th percentiles of classifi cation. If all polyp specimens were 
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cation rate, the average endoscopist ADR would be 42%. If we instead apply the pathologist's classifi cation rate at the 25th and 75th percentile, the average endoscopist ADR would be 32% and 38%, respectively. For an individual endoscopist, sending all of one's specimens to the pathologist with the lowest adenoma classifi cation rate could decrease ADR by, on average, 19% (range 10-28%). Sending all specimens to the pathologist with the highest adenoma classifi cation rate, on the other hand, would increase ADR by, on average, 20% (range 8-44%). If an endoscopist's specimens were analyzed by the pathologist at the 25th percentile of adenoma classifi cation, their ADR would decrease by 10%, on average, and if they were analyzed by the pathologist at the 75th percentile of adenoma polyp classifi cation, their ADR would increase by 9%, on average.
DISCUSSION
We measured variation in pathologists' adenoma and serrated polyp classifi cation in a large, multi-site sample of colonoscopy exams. Consistent with prior work ( 13, 14, 20, 21 ) , we fi nd substantial variation in classifi cation of serrated polyps that exceeded the variation seen in pathologists' classifi cation of conventional adenomas. Variation in pathologist classifi cation can have a substantial impact on endoscopist performance on quality measures. Th e impact on endoscopist SPDR was dramatic and implies that a substantial portion of the variation observed across endoscopists may be attributable to the pathologist that analyzes the specimens.
analyzed by the pathologist with the lowest versus the highest classifi cation rate, the average SPDR would be 0.5% versus 12%, respectively. If analyzed by the pathologist at the 25th and percentiles of classifi cation rate, the average SPDR would be 5% and 9%, respectively. Figure 3 highlights the range of this impact across physicians.
Another way of framing these results is by the percent change in SPDR. An endoscopist's SPDR would decrease by, on average, 91% (range 53% to 96%) if all the endoscopist's specimens were analyzed by the pathologist with the lowest serrated polyp classifi cation rate. SPDR would increase by, on average, 119% (range 5-1,053%), if analyzed by the pathologist with the highest serrated polyp classifi cation rate. If an endoscopist's specimens were analyzed by the pathologist at the 25th percentile of serrated polyp classifi cation, their SPDR would decrease by 9%, on average, and if they were analyzed by the pathologist at the 75th percentile of serrated polyp classifi cation, their SPDR would increase by 62%, on average.
Th e average ADR among the 119 endoscopists in our sample was 36%. If all the specimens had been analyzed by the pathologist with the lowest adenoma classifi cation rate, the average ADR across the 119 endoscopists would be 28% and if they had been analyzed by the pathologist with the highest adenoma classifi - (2) The number of pathology reports is over a 2-year period.
(3) GI experience was identifi ed for each individual pathologist by local staff. Gourevitch et al. 
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Variation in Pathologist Polyp Classification noma classifi cation can still substantially impact an endoscopist's ADR (increasing or decreasing ADR by roughly 20%). Although identifi cation of conventional adenomas is typically straightforward, it is possible that some pathologists in our sample are not obtaining deeper level sections of the tissue block or there could be disagreement on whether observed epithelial changes are reactive to an infl ammatory processes or adenomatous changes. Interpathologist variation in adenoma classifi cation may be clinically relevant to endoscopists near the threshold of acceptable detection rates who may be inaccurately penalized or rewarded in quality improvement programs based on the pathologist(s) interpreting their polypectomy specimens. Th e strengths of this study are the large sample of pathologists and endoscopists from a range of healthcare systems and the translation of pathologist classifi cation of serrated polyps and adenomas into implications for endoscopists. Our work also has some important limitations. First, though these fi ndings are based on the largest sample of pathologists that has been published to date and the pathologists are similar in gender and years of practice to pathologists across the nation, it is unknown how representative our sample is of all pathologists. Second, we did not independently review pathology specimens to measure misclassifi cation. Th e variation we observe in classifi cation by pathologists is presumably driven by variation in pathologist assessment. However given this limitation, we do not know whether it is "better" or clinically more accurate to send specimens to a pathologist with a higher or lower classifi cation rate. Future work should assess the relative accuracy of pathologists with high and low classifi cation rate and the implications of pathologist variation on patients' clinical outcomes. Finally, we focus is on pre-malignant serrated polyps, excluding hyperplastic polyps, and cannot distinguish between types of serrated polyps. However, our inability to distinguish between types of serrated polyps is less of a concern because prior research has highlighted that the vast majority of pre-malignant serrated polyps are sessile serrated adenomas/polyps ( 42, 43 ) .
In summary, among a large, multi-site sample of US pathologists, we fi nd that, aft er accounting for endoscopist variation, there is substantial pathologic variation in interpretation of premalignant colorectal polyps, especially serrated polyps. Th is variation can have a substantial eff ect on endoscopists' quality performance on SPDR and ADR.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
✓ There is variation in pathologist classifi cation of polyps removed during colonoscopy.
WHAT IS NEW HERE
✓ Use of clinical data from a large multi-site sample of pathologists.
✓ Application of a novel method to quantify how variation in pathologist classifi cation impacts endoscopists' quality scores.
✓ Variation in pathologist classifi cation can have a dramatic impact on endoscopist quality scores, especially serrated polyp detection rate.
